Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPOLIZUMAB Cause Blood glucose increased? 112 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Blood glucose increased have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.3% of all adverse event reports for MEPOLIZUMAB.

112
Reports of Blood glucose increased with MEPOLIZUMAB
0.3%
of all MEPOLIZUMAB reports
4
Deaths
61
Hospitalizations

How Dangerous Is Blood glucose increased From MEPOLIZUMAB?

Of the 112 reports, 4 (3.6%) resulted in death, 61 (54.5%) required hospitalization, and 2 (1.8%) were considered life-threatening.

Is Blood glucose increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 112 reports have been filed with the FAERS database.

What Other Side Effects Does MEPOLIZUMAB Cause?

Asthma (11,033) Dyspnoea (9,192) Wheezing (6,093) Product dose omission issue (5,873) Cough (4,577) Pneumonia (4,107) Therapeutic product effect incomplete (4,106) Drug ineffective (3,880) Loss of personal independence in daily activities (3,566) Fatigue (2,656)

What Other Drugs Cause Blood glucose increased?

INSULIN LISPRO (31,969) INSULIN GLARGINE (19,234) DULAGLUTIDE (9,119) INSULIN HUMAN (8,704) INSULIN ASPART (4,743) METFORMIN (4,038) EXENATIDE (3,363) INSULIN DEGLUDEC (2,644) SEMAGLUTIDE (2,240) TIRZEPATIDE (2,240)

Which MEPOLIZUMAB Alternatives Have Lower Blood glucose increased Risk?

MEPOLIZUMAB vs MEPROBAMATE MEPOLIZUMAB vs MERCAPTOPURINE MEPOLIZUMAB vs MEROPENEM MEPOLIZUMAB vs MEROPENEM ANHYDROUS MEPOLIZUMAB vs MESALAMINE

Related Pages

MEPOLIZUMAB Full Profile All Blood glucose increased Reports All Drugs Causing Blood glucose increased MEPOLIZUMAB Demographics